1-3
2026
影响因子区间
—
平台估算
31%
2025
中国作者发文占比
1969 USD
收费
期刊简介:Translational Vision Science & Technology (TVST), an official journal of the Association for Research in Vision and Ophthalmology (ARVO), an international organization whose purpose is to advance research worldwide into understanding the visual system and preventing, treating and curing its disorders, is an online, open access, peer-reviewed journal emphasizing multidisciplinary research that bridges the gap between basic research and clinical care. A highly qualified and diverse group of Associate Editors and Editorial Board Members is led by Editor-in-Chief Marco Zarbin, MD, PhD, FARVO.The journal covers a broad spectrum of work, including but not limited to:Applications of stem cell technology for regenerative medicine,Development of new animal models of human diseases,Tissue bioengineering,Chemical engineering to improve virus-based gene delivery,Nanotechnology for drug delivery,Design and synthesis of artificial extracellular matrices,Development of a true microsurgical operating environment,Refining data analysis algorithms to improve in vivo imaging technology,Results of Phase 1 clinical trials,Reverse translational ("bedside to bench") research.TVST seeks manuscripts from scientists and clinicians with diverse backgrounds ranging from basic chemistry to ophthalmic surgery that will advance or change the way we understand and/or treat vision-threatening diseases. TVST encourages the use of color, multimedia, hyperlinks, program code and other digital enhancements.
【译文】转化视觉科学与技术(TVST),是视觉与眼科研究协会(ARVO)的官方期刊,ARVO是一个旨在全球范围内推进对视觉系统的研究,预防和治疗其疾病的国际组织。这是一本在线、开放获取、同行评审的期刊,强调跨学科研究,弥合基础研究与临床护理之间的差距。由总编辑Marco Zarbin,MD,PhD,FARVO领导的一支高素质且多元化的副编辑和编委会成员团队。该期刊涵盖广泛的研究领域,包括但不限于:干细胞技术在再生医学中的应用、开发人类疾病的新动物模型、组织生物工程、化学工程改善基于病毒的基因递送、纳米技术用于药物递送、人工细胞外基质的构建与合成、开发真正的显微外科手术环境、优化数据分析算法以改进体内成像技术、I期临床试验结果、逆向转化("床边到实验室”)研究。TVST寻求来自具有不同背景的科学家和临床医生的手稿,从基础化学到眼科手术,以推进或改变我们对威胁视力疾病的理解和/或治疗方法。TVST鼓励使用彩色、多媒体、超链接、程序代码和其他数字增强功能。
| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q2 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |